BRF
KIN

B. Riley Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

B. Riley Financial’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,000
Closed -$183K – 94
2019
Q1 		$183K Sell
20,000
-5,000
-20% -$50.8K 0.07% 70
2018
Q4 		$274K Sell
25,000
-10,000
-29% -$126K 0.15% 71
2018
Q3 		$488K Buy
35,000
+15,000
+75% +$203K 0.14% 108
2018
Q2 		$213K Sell
20,000
-109,513
-85% -$1.07M 0.06% 271
2018
Q1 		$1.12M Buy
+129,513
New +$1.14M 0.31% 76

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

B. Riley Financial's KIN Position: Q2 2019 in Review

B. Riley Financial sold out of Kindred Biosciences, Inc. (KIN) in Q2 2019, closing a stake of 20,000 shares — an estimated $183K sold.

B. Riley Financial first reported a position in KIN in Q1 2018 and held it in 5 quarters. The position peaked at $1.12M in Q1 2018. 75 funds tracked by Wall St. Rank hold KIN as of Q2 2019.

  • B. Riley Financial reported no remaining Kindred Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • B. Riley Financial sold 20,000 Kindred Biosciences, Inc. shares in Q2 2019, an estimated $183K.
  • B. Riley Financial first reported a position in Kindred Biosciences, Inc. in Q1 2018 and held it in 5 quarters.
  • B. Riley Financial's Kindred Biosciences, Inc. position peaked at $1.12M in Q1 2018.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2019.

Based on B. Riley Financial's 13F filing for Q2 2019, filed 12 Aug 2019.